Gene expression correlation of immune checkpoint molecules Siglec-15 and PD-L1 varies widely by cancer indication

被引:0
|
作者
Watkins, Krystal
Diao, Liyang
Crochiere, Marsha
Pinkas, Jan
机构
关键词
D O I
10.1158/1538-7445.AM2024-1373
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1373
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Core needle biopsies alter the amounts of CCR5, Siglec-15, and PD-L1 positivities in breast carcinoma
    Mutka, Minna
    Joensuu, Kristiina
    Heiskala, Marja
    Eray, Mine
    Heikkila, Paeivi
    VIRCHOWS ARCHIV, 2023, 483 (02) : 215 - 224
  • [22] Immunohistochemistry of Immune Checkpoint Markers PD-1 and PD-L1 in Prostate Cancer
    Sharma, Meenal
    Yang, Qi
    Mcmahon, Loralee
    Miyamoto, Hiroshi
    MODERN PATHOLOGY, 2019, 32
  • [23] Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
    Iosune Baraibar
    Ignacio Melero
    Mariano Ponz-Sarvise
    Eduardo Castanon
    Drug Safety, 2019, 42 : 281 - 294
  • [24] Immunohistochemistry of Immune Checkpoint Markers PD-1 and PD-L1 in Prostate Cancer
    Sharma, Meenal
    Yang, Qi
    Mcmahon, Loralee
    Miyamoto, Hiroshi
    LABORATORY INVESTIGATION, 2019, 99
  • [25] PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
    Hartkopf, Andreas D.
    Taran, Florin-Andrei
    Wallwiener, Markus
    Walter, Christina B.
    Kraemer, Bernhard
    Grischke, Eva-Maria
    Brucker, Sara Y.
    BREAST CARE, 2016, 11 (06) : 385 - 390
  • [26] Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
    Baraibar, Iosune
    Melero, Ignacio
    Ponz-Sarvise, Mariano
    Castanon, Eduardo
    DRUG SAFETY, 2019, 42 (02) : 281 - 294
  • [27] Immunohistochemistry of immune checkpoint markers PD-1 and PD-L1 in prostate cancer
    Sharma, Meenal
    Yang, Zhiming
    Miyamoto, Hiroshi
    MEDICINE, 2019, 98 (38)
  • [28] Cancer cell expression of CCR2 regulates the PD-L1/PD-1 immune checkpoint in breast cancer
    Fein, Miriam R.
    Almeida, Ana S.
    Eberhardt, Anais
    Egeblad, Mikala
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [29] Cancer Immunotherapy: An Overview of Small Molecules as Inhibitors of the Immune Checkpoint PD-1/PD-L1 (2015-2021)
    Baglini, Emma
    Salerno, Silvia
    Barresi, Elisabetta
    Marzo, Tiziano
    Da Settimo, Federico
    Taliani, Sabrina
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2022, 22 (14) : 1816 - 1827
  • [30] Correlation between PD-L1 expression and PD-1 immune checkpoint blockade: A retrospective analysis for advanced melanoma.
    Cho, Jinhyun
    Ahn, Soomin
    Yoo, Kwai Han
    Song, Haa-Na
    Jung, Ki Sun
    Jang, Kee-Taek
    Lee, Jeeyun
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)